Dry AMD is a progressive disease
MACUMIRA offers a non-invasive solution for Dry AMD, using microcurrent technology to stabilize and potentially improve vision. It targets the retina to enhance cellular function and promote eye health.
01. Micro current Technology
Painlessly delivered across closed eyelids with no injections, systemic drugs, or adverse side effects.
02. Patented waveform
Developed to maximize efficacy while leaving the delicate structures of the eye undamaged.
03. Patented delivery system
That is simple to use and easily administered by a certified Eyecare Practitioner or Ophthalmic Technician.
04. Immediate results
Optimal visual improvement reached after initial treatment schedule of 4 sessions over 10 days
05. Visual improvements
on average of 2 lines on the EyeChart & Maintained with 1x treatment every 2-3 months.
06. Mechanism of Action
Stimulated Retinal Pigment Epithelium (RPE) cells enhanced Mitochondrial ATP formation leads to improved cellular function and clearing of drusen and other macular waste by-products.
Macumira Device Head Set - front view
Macumira MicroCurrent Controler Unit
Macumira Device Head Set - Side view
OCT Scan of Dry AMD
Above are very reputable Medical Institutions that endorse MACUMIRA including Toronto Retina Inst below
This is some text inside of a div block.
This is some text inside of a div block.
905-592-3963 | clinic@drmvarshney.ca | Dr. Malini Varshney, OD | Halton Family Health Center | 2951 Walkers Line Burlington ON L7M 4Y1
Clinic Hours: Monday: 9:00am-7:00pm | Tuesday: 8:00am-6:00pm | Wednesday: 10:00am-6:00pm | Thursday: 8:00am-6:00pm | Friday: 8:00am-6:00pm